Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olopatadine cream versus fluocinolone cream for hand eczema
IRCT20240614062122N1Phase 2Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Jul 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hand dermatitis comparing Olopatadine cream with Fluocinolone cream (2 arms). Primary endpoints: Reduction in topical corticosteroid use, Skin barrier restoration and 3 more. Started Jul 2024; status: completed.
02
Drugs
olopatadinefluocinolone
03
Conditions
hand dermatitis
Beyond the preview
Go deeper on IRCT20240614062122N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240614062122N1.